Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer
Status:
Not yet recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
Study to determine the feasibility of Sentinel Lymph Node (SLN) mapping using novel magnetic
tracers (FerroTrace) and indocyanine green (ICG) for colorectal cancer; and to evaluate
safety by assessing short term toxicity associated with colonoscopic peritumoral injection of
novel magnetic nanoparticles (FerroTrace) and ICG for colorectal cancer.